1011 related articles for article (PubMed ID: 26457017)
1. Biomarkers for the early diagnosis of hepatocellular carcinoma.
Tsuchiya N; Sawada Y; Endo I; Saito K; Uemura Y; Nakatsura T
World J Gastroenterol; 2015 Oct; 21(37):10573-83. PubMed ID: 26457017
[TBL] [Abstract][Full Text] [Related]
2. Circulating predictive and diagnostic biomarkers for hepatitis B virus-associated hepatocellular carcinoma.
Van Hees S; Michielsen P; Vanwolleghem T
World J Gastroenterol; 2016 Oct; 22(37):8271-8282. PubMed ID: 27729734
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic specificity and sensitivity of PIVKAII, GP3, CSTB, SCCA1 and HGF for the diagnosis of hepatocellular carcinoma in patients with alcoholic liver cirrhosis.
Unić A; Derek L; Duvnjak M; Patrlj L; Rakić M; Kujundžić M; Renjić V; Štoković N; Dinjar P; Jukic A; Grgurević I
Ann Clin Biochem; 2018 May; 55(3):355-362. PubMed ID: 28766361
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic and prognostic value of alpha-fetoprotein, des-γ-carboxy prothrombin and squamous cell carcinoma antigen immunoglobulin M complexes in hepatocellular carcinoma.
Bertino G; Neri S; Bruno CM; Ardiri AM; Calvagno GS; Malaguarnera M; Toro A; Malaguarnera M; Clementi S; Bertino N; Di Carlo I
Minerva Med; 2011 Oct; 102(5):363-71. PubMed ID: 22193346
[TBL] [Abstract][Full Text] [Related]
5. Clinical biomarkers in hepatocellular carcinoma (HCC).
Donati M; Brancato G; Donati A
Front Biosci (Schol Ed); 2010 Jan; 2(2):571-7. PubMed ID: 20036969
[TBL] [Abstract][Full Text] [Related]
6. Search for Effective Serum Tumor Markers for Early Diagnosis of Hepatocellular Carcinoma Associated with Hepatitis C.
Malov SI; Malov IV; Kuvshinov AG; Marche PN; Decaens T; Macek-Jilkova Z; Yushchuk ND
Sovrem Tekhnologii Med; 2021; 13(1):27-33. PubMed ID: 34513063
[TBL] [Abstract][Full Text] [Related]
7. The GALAD scoring algorithm based on AFP, AFP-L3, and DCP significantly improves detection of BCLC early stage hepatocellular carcinoma.
Best J; Bilgi H; Heider D; Schotten C; Manka P; Bedreli S; Gorray M; Ertle J; van Grunsven LA; Dechêne A
Z Gastroenterol; 2016 Dec; 54(12):1296-1305. PubMed ID: 27936479
[No Abstract] [Full Text] [Related]
8. Controversies regarding and perspectives on clinical utility of biomarkers in hepatocellular carcinoma.
Song PP; Xia JF; Inagaki Y; Hasegawa K; Sakamoto Y; Kokudo N; Tang W
World J Gastroenterol; 2016 Jan; 22(1):262-74. PubMed ID: 26755875
[TBL] [Abstract][Full Text] [Related]
9. VWF/ADAMTS13 ratio as a potential biomarker for early detection of hepatocellular carcinoma.
Takaya H; Namisaki T; Kitade M; Kaji K; Nakanishi K; Tsuji Y; Shimozato N; Moriya K; Seki K; Sawada Y; Saikawa S; Sato S; Kawaratani H; Akahane T; Noguchi R; Matsumoto M; Yoshiji H
BMC Gastroenterol; 2019 Oct; 19(1):167. PubMed ID: 31638892
[TBL] [Abstract][Full Text] [Related]
10. New perspectives and strategy research biomarkers for hepatocellular carcinoma.
Saffroy R; Pham P; Reffas M; Takka M; Lemoine A; Debuire B
Clin Chem Lab Med; 2007; 45(9):1169-79. PubMed ID: 17635075
[TBL] [Abstract][Full Text] [Related]
11. Elevated alpha-fetoprotein: differential diagnosis - hepatocellular carcinoma and other disorders.
Wong RJ; Ahmed A; Gish RG
Clin Liver Dis; 2015 May; 19(2):309-23. PubMed ID: 25921665
[TBL] [Abstract][Full Text] [Related]
12. Studying the Impact of Golgi Protein 73 Serving as a Candidate Biomarker in Early Diagnosis for Hepatocellular Carcinoma among Saudi Patients.
Farag RMA; Al Ayobi D; Alsaleh KA; Kwon HJ; EL-Ansary A; Dawoud EA
Asian Pac J Cancer Prev; 2019 Jan; 20(1):215-220. PubMed ID: 30678434
[TBL] [Abstract][Full Text] [Related]
13. Role of Biomarkers and Biopsy in Hepatocellular Carcinoma.
Chen VL; Sharma P
Clin Liver Dis; 2020 Nov; 24(4):577-590. PubMed ID: 33012446
[TBL] [Abstract][Full Text] [Related]
14. [Significance of arginase-1, glypican-3, hepatocyte paraffin antigen 1 and alpha-fetoprotein in diagnosis and differential diagnosis of liver tumors].
Li J; Wei L
Zhonghua Bing Li Xue Za Zhi; 2014 Apr; 43(4):246-50. PubMed ID: 24915815
[TBL] [Abstract][Full Text] [Related]
15. Combination of triple biomarkers AFP, AFP-L3, and PIVAKII for early detection of hepatocellular carcinoma in China: Expectation.
Gao J; Song P
Drug Discov Ther; 2017; 11(3):168-169. PubMed ID: 28757516
[TBL] [Abstract][Full Text] [Related]
16. Des-gamma-carboxyprothrombin for early identification and prognosis of hepatocellular carcinoma--a case control study from western Nepal.
Mittal A; Gupta SP; Sathian B; Sreedharan J; Poudel B; Yadav SK; Pandeya DR
Asian Pac J Cancer Prev; 2012; 13(11):5773-5. PubMed ID: 23317255
[TBL] [Abstract][Full Text] [Related]
17. Rationale and design of the Hepatocellular carcinoma Early Detection Strategy study: A multi-center longitudinal initiative of the National Cancer Institute's Early Detection Research Network.
Borges KA; Dai J; Parikh ND; Schwartz M; Nguyen MH; Roberts LR; Befeler AS; Srivastava S; Rinaudo JA; Feng Z; Marrero JA; Reddy KR
Contemp Clin Trials; 2019 Jan; 76():49-54. PubMed ID: 30439517
[TBL] [Abstract][Full Text] [Related]
18. Cancer biomarkers for hepatocellular carcinomas: from traditional markers to recent topics.
Masuda T; Miyoshi E
Clin Chem Lab Med; 2011 Jun; 49(6):959-66. PubMed ID: 21428856
[TBL] [Abstract][Full Text] [Related]
19. Hepatocellualar carcinoma serum markers.
Bertino G; Ardiri A; Malaguarnera M; Malaguarnera G; Bertino N; Calvagno GS
Semin Oncol; 2012 Aug; 39(4):410-33. PubMed ID: 22846859
[TBL] [Abstract][Full Text] [Related]
20. [Application of alpha-fetoprotein and osteopontin combination for early diagnosis of hepatocellular carcinoma associated with hepatitis C.].
Malov SI; Malov IV; Dvornichenko VV; Rasulov RI; Kuvshinov AG; Marche PN; Decaens T; Macek-Jilkova Z; Yushchuk ND
Klin Lab Diagn; 2019; 64(10):607-612. PubMed ID: 31742954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
